Sp1153

PANEL DISCUSSION

Date
May 21, 2024

Presenters

Speaker Image for Jason Samarasena
University of California, Irvine
Speaker Image for Aasma Shaukat
New York University
Speaker Image for Sidhartha Sinha
Speaker Image for Dennis Shung
Yale University School of Medicine

Tracks

Related Products

Thumbnail for IMPACT OF ARTIFICIAL INTELLIGENCE SYSTEMS FOR UPPER GASTROINTESTINAL BLEEDING ON CLINICIAN TRUST AND LEARNING USING LARGE LANGUAGE MODELS: A RANDOMIZED PILOT SIMULATION STUDY
IMPACT OF ARTIFICIAL INTELLIGENCE SYSTEMS FOR UPPER GASTROINTESTINAL BLEEDING ON CLINICIAN TRUST AND LEARNING USING LARGE LANGUAGE MODELS: A RANDOMIZED PILOT SIMULATION STUDY
Artificial intelligence (AI)-based risk stratification systems in upper gastrointestinal bleeding (UGIB) outperform existing risk scores, but successful implementation of such systems into practice requires acceptance and trust of the technology by clinicians…
Thumbnail for AUTOMATED IDENTIFICATION OF RECURRENT GASTROINTESTINAL BLEEDING USING ELECTRONIC HEALTH RECORDS AND LARGE LANGUAGE MODELS
AUTOMATED IDENTIFICATION OF RECURRENT GASTROINTESTINAL BLEEDING USING ELECTRONIC HEALTH RECORDS AND LARGE LANGUAGE MODELS
Recurrent gastrointestinal bleeding (GIB) occurs in up to 20% of patients hospitalized with GIB and is a major cause of morbidity and mortality. Early identification of recurrent bleeding may improve patient management and outcomes…
Thumbnail for AMONG PATIENTS WITH IBD USE OF STATINS IS ASSOCIATED WITH LOWER RISK OF DEVELOPING DE NOVO PRIMARY SCLEROSING CHOLANGITIS
AMONG PATIENTS WITH IBD USE OF STATINS IS ASSOCIATED WITH LOWER RISK OF DEVELOPING DE NOVO PRIMARY SCLEROSING CHOLANGITIS
BACKGROUND: Primary sclerosing cholangitis (PSC) is a progressive, cholestatic liver disease without medical cure, that confers a significantly elevated risk of malignancy, acute cholangitis and cirrhosis. Approximately 2-7% of patients with inflammatory bowel disease (IBD) will develop PSC…
Thumbnail for VITAMIN D DIFFERENTIALLY REGULATES MUCOSAL IMMUNOGLOBULIN BINDING TO GUT MICROBIOTA AND DENDRITIC CELL-B CELL SIGNALING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
VITAMIN D DIFFERENTIALLY REGULATES MUCOSAL IMMUNOGLOBULIN BINDING TO GUT MICROBIOTA AND DENDRITIC CELL-B CELL SIGNALING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
BACKGROUND: Loss of immune tolerance to commensal gut bacteria plays a critical role in the pathogenesis of inflammatory bowel disease (IBD). Prior studies have demonstrated that immunoglobulin (Ig) binding to the gut microbiota is altered in IBD and associated with disease activity…